About
Technology
Issues
FAQ
Links
Official Page
New Therapies Targeting apoB Metabolism for High-Risk Patients with Inherited Dyslipidaemias: What Can the Clinician Expect?
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.